SRA downsizes with sale of research group

SRA Global Clinical Development group sold to biopharmaceutical Aptiv Solutions

SRA International Inc. has sold its contract research organization, SRA Global Clinical Development LLC, to biopharmaceutical Aptiv Solutions Inc., SRA announced Oct. 3.

Financial terms of the transaction, which is effective immediately, were not disclosed.

“We believe the GCD business, as a part of Aptiv Solutions, has greater opportunity to pursue a wider range of initiatives that align with its mission,” SRA President and CEO Bill Ballhaus said in the announcement.

SRA announced earlier this year that it had decided to divest SRA Global Clinical Development and its wholly owned subsidiaries.

Aptiv Solutions, of Reston, Va., is a global biopharmaceutical and medical device development services company focused on recognizing, understanding and enabling clients to capitalize on rapid and fundamental changes facing companies developing products in the pharmaceutical, biotech and medical device market, the announcement explained.

SRA International Inc., of Fairfax, Va., ranks No. 29 on Washington Technology’s 2011 Top 100 list of the largest federal government contractors.

About the Author

David Hubler is the former print managing editor for GCN and senior editor for Washington Technology. He is freelance writer living in Annandale, Va.

Reader Comments

Please post your comments here. Comments are moderated, so they may not appear immediately after submitting. We will not post comments that we consider abusive or off-topic.

Please type the letters/numbers you see above

What is your e-mail address?

My e-mail address is:

Do you have a password?

Forgot your password? Click here
close

Trending

  • POWER TRAINING: How to engage your customers

    Don't miss our June 7 Washington Technology Power Training session on Mastering Stakeholder Engagement, where you'll learned the critical skills you need to more fully connect with your customers and win more business. Read More

  • PROJECT 38 PODCAST

    In our latest Project 38 Podcast, editor Nick Wakeman and senior staff writer Ross Wilkers discuss the major news events so far in 2019 and what major trends are on the horizon. Read More

contracts DB

Washington Technology Daily

Sign up for our newsletter.

Terms and Privacy Policy consent

I agree to this site's Privacy Policy.